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Objectives
To describe health-care use by persons with HIV in an urban area of Switzerland (Zurich). Further, to
compare the different health-care settings.
Design
A 1-year prospective cohort study recruiting 60 patients at general practices and 60 patients at a
specialized university outpatient clinic.
Methods
Patients and their treating physicians were interviewed or answered questionnaires, respectively, at
baseline, month 6 and 12.
Results
During the study period, five patient groups were identified among the 106 enrolled patients, of
whom (i) 42% saw a general practitioner exclusively, (ii) 31% were treated at the specialized
outpatient clinic, (iii) 8% were in shared care, (iv) 10% changed health-care model, and (v) 9% were
lost to follow-up. Baseline demographic, psychosocial and clinical data were similar among patient
groups. At study end, the proportion of patients with HIV-1 RNA o 400 copies/mL was 72%, 74%,
88%, 55% among groups (i) to (iv), respectively (ns), and 22% at month 6 among those lost to
follow-up. Indicators for quality of care were similarly good among all patient groups.
Conclusions
A well-working system offers high-quality healthcare to persons living with HIV, where existing
teams of speciality and primary health-care professionals efficiently and effectively co-operate.
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Introduction
In the epidemic’s first decade, care for people with HIV
or AIDS was provided to a large extent by general
practitioners. The introduction of highly active antiretro-
viral therapy re-opened the discussion on the qualifica-
tions and expertise needed for high-quality care. There
was growing support for the argument that multidrug
antiretroviral regimens were so complex that generalists
in primary care would have difficulties in maintai-
ning sufficient expertise in this area [1, 2]. Recent studies,
however, have shown that primary care physicians,
with a certain level of experience and commitment to
ongoing HIV education, can deliver high-quality care
[3–8].
Possible advantages of being treated by primary care
physicians have been elaborated. As HIV infection is a
chronic, not curable and potentially life-threatening ill-
ness, management requires extensive education, counsel-
ling and emotional support of affected individuals
and other persons to whom they relate. Apart from
these skills that may better be met by primary care
medicine, other characteristics, that do not only apply
Correspondence: Julie Page, Institute of Social and Preventive Medicine,
University of Zurich, Sumatrastrasse 30, 8006 Zurich, Switzerland.
Tel: 1 41 1634 46 02; fax: 1 41 1634 49 62; e-mail: page@ifspmunizhch
*Contributed equally
HIV Medicine (2003), 4, 276–286 r 2003 British HIV Association
276
to individual physicians, but rather to the system they
work in, may be important determinants of patient
outcome [1–3]. Such characteristics include accessibility,
continuity, co-ordination and comprehensiveness of ser-
vices [9]. A model has been suggested where primary
care by a generalist is conjoined with consultation from
and co-operation with a specialist so as to combine
the advantages of primary care with expertise on the
rapid developments in HIV medicine [3, 10, 11]. In several
other chronic illnesses – such as asthma and diabetes – this
has been shown to be a fruitful relationship [12–14].
We investigated healthcare for people with HIV in
the urban area of Zurich, Switzerland, where health
insurance covers the whole population and guarantees
free choice of physicians. HIV-specific care is provided
by specialists at a university-based HIV outpatient clinic
as well as by general practitioners. Our objectives were
(i) to describe the different healthcare use by patients.
Further, to compare the different healthcare settings with
regard to (ii) patient’s characteristics; (iii) the quality of
care with regard to several indicators (treatment outcome,
prescribed therapy, adherence, quality of life and patients’
satisfaction with care setting); (iv) the patients’ evalua-
tion of different health service dimensions (interaction of
providers with patients, non-personal qualities of care
setting) and (v) physicians’ characteristics.
Participants and methods
Study design
We conducted a prospective cohort study of people
with HIV who were enrolled by six physicians (fellows)
at the specialized university HIV outpatient clinic and
by 10 general practitioners in the urban area of Zurich,
Switzerland. Data on patients were collected at baseline,
month 6 and 12. Clinical data were reported by the treating
physician using standardized questionnaires; all other
patients’ data were collected by trained interviewers
using standardized and semi-standardized questionnaires.
The physicians answered a questionnaire on physicians’
characteristics at baseline.
Institutions and physicians
The fellows were in a 1-year rotating position at the
Division of Infectious Diseases and Hospital Epidemiology
at the University Hospital, and mostly in postgraduate
training to become a specialist in internal medicine,
infectious diseases or general practice. Experienced staff
physicians specialized in infectious diseases closely super-
vises them in their work. The practitioners, mostly
specialists in general or internal medicine, were recruited
within a group of physicians, named ‘HIV-Pract’. These
physicians all actively treat patients with HIV and HIV-
Pract has been organizing monthly meetings for teaching
and network purposes since 1993.
Patient selection
We aimed at enrolling 120 participants, 60 at the HIV
outpatient clinic and 60 in general practices, assigning a
predefined number of a maximum of 10 patients to each
physician. Between January and August 1999, patients
who met the inclusion criteria were consecutively asked for
participation when they were attending their physicians,
the criteria being: (1) an individual with HIV on
antiretroviral therapy; (2) patient having had at least three
prior consultations with the same physician; and (3) the
patient being willing to give written informed consent.
Measures
Patients’ characteristics
Demographic characteristics, psychosocial measures and
clinical data were assessed. Depressive symptoms were
assessed using Beck Depression Inventary (scale range
0–63, higher scores meaning more depressed mood) [15].
Sense of Coherence was used for personality measurement
(scale range: 13–65, higher scores indicating higher sense
of coherence) [16]. On a visual analogue scale with a range
from 0 to 100 the patients indicated their current physical
wellbeing (0, very bad; 100, very good). Patients’ history,
clinical data including HIV-disease stage, comorbidity,
detailed medication and side effects were documented.
Plasma HIV-1 RNA concentration was determined by the
Amplicor HIV-1 Monitor (Roche Diagnostics, Basle, Swit-
zerland) with a limit of detection of 400 copies/mL, in some
patients using the ultrasensitive assay (limit of detection
o50 copies/mL).
Course of HIV infection
Course of CD4 lymphocyte counts, HIV-1 RNA levels and
antiretroviral therapy were documented prospectively over
1 year.
The use of healthcare
The use of healthcare was documented at each time point
according to the question: ‘What healthcare model are you
currently in – exclusively seeing a general practitioner,
exclusively attending the outpatient clinic or being in
shared care (i.e. simultaneously seeing a specialist and a
general practitioner)?
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Evaluation of antiretroviral therapy
One infectious diseases specialist (RW) and one general
practitioner (RJ) rated the therapy of the individual patients
as (i) successful, (ii) not successful but plausible, (iii) not
successful and not plausible, and (iv) no judgement
possible according to graphs on the course of HIV
surrogate markers during the study and treatment history.
Access to the original patient chart was not possible and
the experts did not interview or examine the patients.
Treatment was considered successful if: (i) CD4 cell counts
were rising or stable during the 1-year follow-up and were
above 200 cells/mL, irrespective of viral load, or (ii) if viral
load decreased to, or was below, the level of detection
during the 1-year period, irrespective of CD4 cell counts, or
(iii) if unsuccessful antiretroviral therapy leading to
virologic failure was changed during the follow-up to a
salvage regimen containing at least two new drugs, if
available. Treatment was considered plausible (but not
successful) if the criteria mentioned above were not met,
but clinically acceptable reasons not to change antiretro-
viral drugs were evident (e.g. no potentially better
treatment regimen was at hand, based upon patient’s
treatment history; or comorbidity, psychosocial variables
and drug use). Whereas resistance testing in the case of
virologic failure, as well as assessments of drug levels
became the standard of care at the study institutions, these
methods were neither available nor reimbursed by health
insurance companies at the time period when the study was
performed, i.e. between 1999 and 2001.
Adherence to antiretroviral therapy
The patients were asked by the interviewer using visual
analogue scales ranging from 0 to 100% to estimate the
proportion of drugs they had taken: (i) at the correct time
and (ii) in the correct amount the day before the interview;
the average of these two measures was taken as a proxy for
adherence.
Quality of life
We used the FAHI (Functional Assessment of Human
Immunodeficience Virus Infection), a questionnaire con-
sisting of 44 items (scale range: 0–176; higher scores
indicating higher quality of life) [17, 18].
Patients’ satisfaction. evaluation of health service
dimensions
Prior to this study, focus group discussions were conducted
to assess dimensions important for the care of people with
HIV [19, 20]. On the basis of these results we developed
structured questions concerning: (i) the overall satisfaction
of each patient with his/her healthcare model; (ii) the
satisfaction with aspects related to the treating physician
(competence, continuity, course of a visit); and (iii) the
evaluation of different health-care dimensions (interaction
of providers with patients, non-personal qualities of care
setting). The satisfaction scales ranged from 1 (not
satisfied) to 5 (very satisfied), the scales concerning
dimensions of health-care provision from 1 (is not at all
true) to 5 (is very true).
Physicians’ characteristics
A questionnaire on demographic data and physicians’
experience with care of persons living with HIV was used.
Statistics
To assess differences in the patients’ and physicians’
characteristics, we conducted cross-sectional comparative
analyses for baseline data. Further, we compared different
patient groups cross-sectionally at all three time points: (i)
three groups of patients, who stayed in the same health-
care model during the study period; (ii) patients who stayed
in a stable health-care model during the study period vs.
patients who changed model during the observed time; (iii)
patients, who withdrew from the study vs. patients, who
stayed enrolled during the whole study (including patients
who died during the study).
Categorical data were subjected to Pearson’s w2 or Fisher’s
exact test. To compare continuous data an analysis of
variance (post hoc comparison Scheffe´ test, Po0.05) and for
the comparison of two groups Student’s t-test for indepen-
dent samples were used. If the data were skewed, non-
parametric tests (Kruskal–Wallis variance analysis or Wil-
coxon Mann–Whitney U-test) were used. All analyses were
performed using SPSS 6.1 for Macintosh (SPSS Inc.,
Chicago, IL, USA).
Results
Participation of patients
Out of 200 patients asked for enrolment, a total of 120
patients gave written consent and 106 patients were
questioned at baseline. There were no significant differences
in age or sex between individuals who were enrolled and
those who rejected to participate. During the study, nine
patients were lost to follow-up and two patients died (Fig. 1).
Patient groups identified during study period
Among the 106 patients who were enrolled either at the HIV
outpatient clinic or by general practitioners, five patient
groups were identified: (1) A total of 45 (42.5%) patients
exclusively saw their general practitioner; (2) 33 (31.1%)
exclusively attended the specialized clinic; (3) eight (7.5%)
278 J Page et al.
r 2003 British HIV Association HIV Medicine (2003) 4, 276–286
were in shared care seeing a specialist at the clinic as well as
a general practitioner; (4) 11 (10.4%) changed their care
setting during the course of the study; and (5) nine patients
(8.5%) were lost to follow-up. Out of those 11 patients who
changed their health-care model during follow-up, a
majority was in shared care at baseline (Fig. 1).
Patients’ characteristics at baseline
Of the 106 patients 83 were male (78.3%), 57 (53.8%) lived
in the town of Zurich, 35 (33%) had a high school or higher
education, 10 (9.7%) obtained welfare, 54 (55.1%) were
homosexual and 42 (39.6%) had a history of substance use.
Their mean age was 39.9 (7 7.5) years and their mean
income per month was SFr. 4317.30 (7 7.5) (i.e. 2854.04
US$). The median CD4 count among all study participants
was 352 cells/mL (range: 29–1390), median HIV-1 RNA 36
copies/mL (0–233 196). Median nadir CD4 count was 132.5
cells/mL, ranging from 0 to 760 cells/mL. Previous AIDS was
documented in 27.9% of the participants. We found low
mean (7SD) scores using Beck Depression Inventory (i.e.
few depressive symptoms) (8.976.9), high mean scores
regarding sense of coherence (48.877.6), and high mean
scores with respect to physical wellbeing (78.1717.4).
No statistically significant differences were found
between the three groups of patients, who stayed in the
same healthcare model during the study period (i.e. general
practice, outpatient clinic, shared care) (Table 1).
A comparison of the 11 participants who changed the
health-care model during follow-up and the 86 individuals
who remained in the same care model revealed no
statistically significant differences (Table 1).
Clinical course of HIV infection
CD4 lymphocyte counts and the proportion of individuals
with HIV-1 RNA concentrations below 400 copies/mL
among the different patient groups are depicted in Fig. 2. A
total of four patients developed a new AIDS-defining
disease and two patients died during the study.
At study end the median CD4 cell count (range) in the
three stable patient groups was 459 cells/mL (120–1442
cells/mL) for the general practice group, 449 cells/mL (79–
891 cells/mL) for the clinic group, and 303.5 cells/mL (104–
751 cells/mL) for patients in shared care (ns). The proportion
of participants with viral load below 400 copies/mL at
study end was 72.1% among patients attending general
practices, 74.2% among patients at the clinic, and 87.5%
among patients in shared care (ns). The proportion rose
during the year in all patient groups especially in the
patients in shared care.
Compared to the patients in a stable health-care model
(n5 86) a lower proportion of the 11 patients who changed
their model during the study had HIV-1 RNA concentra-
tions below 400 copies/mL (baseline: 60% vs. 69%; study
end: 54.5% vs. 74.4%).
Antiretroviral therapy
Standard-of-care antiretroviral therapy was provided to
most patients according to the rating of the experts. The
majority of the whole sample was on a triple combination
at baseline (81.6%). Mean (7 SD) time of being on any
antiretroviral treatment was 2.9 years before study entry
(7 2.0); mean time of being on at least triple antiretroviral
treatment was 2.0 years (7 0.9). During the study, nine
81 asked in practice 119 asked in clinic
60 consented60 consented
7 withdrew
1died  6 withdrew
52 54
enrolled at baseline
45 followed 
in practices
33 followed 
in clinic
8 followed 
in 
shared care
11 followed 
who changed 
care setting
9 lost to 
follow up
1 died 1 died 
Fig. 1 Study profile. Numbers indicate numbers of patients.
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patients stopped antiretroviral therapy, of whom two
restarted. Cessation of treatment was equally distributed
between patients at the clinic and in general practices.
No statistically significant differences were found
between groups treated at the specialized clinic, general
practices or by both institutions (Fig. 2, Table 1).
Adherence to therapy
Self-reported mean adherence to therapy at baseline was
around 95% and similar among the different patient
groups, who stayed in the same health-care model with
the patient group in shared care indicating the highest rates
(Table 1). At study end the mean (7 SD) rate of adherence
was 96.6% (77.8) among those in general practice, 96.8%
(74.1) among patients at the specialized HIV clinic, 100%
(70) among those in shared care, and 96.7% (78.3) among
patients who changed care model during the study. No
statistically significant differences were calculated in any
group comparison (Fig. 2).
Quality of life
Mean quality of life of all study participants was 129.5
(7 22.5) at baseline and 131.6 (7 25.6) at study end.
Those patients who remained in a stable health-care
model obtained high mean scores of quality of life with no
statistically significant differences between the three
groups at any time point (Table 1, not all data shown).
Quality of life changed during the study period among
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Fig. 2 Comparison of indicators for quality of care during 1-year follow-up among five different patient groups: (1) ^ Care by a general
practitioner exclusively (n5 45); (2) & Care at a specialized university outpatient clinic exclusively (n5 33); (3) } Patients in shared care
(n5 8); (4)  Patients who changed from one care model to an other (n5 11); and (5) – Patients who were lost to follow-up (month 0: n5 9;
month 6: n5 3). Panel (a): Proportion of individuals with HIV-1 RNA values less than 400 copies/mL during follow-up (95% CI where
reasonable). Panel (b): Course of CD4 cell counts. Panel (c): Course of quality of life. Panel (d): Course of patients’ satisfaction with care. Panel
(e): Course of adherence. Panel (f): Evaluation of prescribed antiretroviral therapy.
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patients who were in shared care (scores at study end –
general practice: 133.5725.1; outpatient clinic: 134725.5;
shared care: 122.3733.1) (Fig. 2).
In comparison to the patients who changed health-care
model, the patients in a stable treatment situation had
higher quality of life scores (baseline: 126.9722.9 vs.
130.3722.9). At study end mean quality of life was 124.0
(722.1) and 132.6 (7 26), respectively.
Patients’ satisfaction
Mean overall patient satisfaction was high in all patients
during the whole course of the study (baseline: 4.6,7 0.8;
study end: 4.5 7 0.8). Statistically significant differences
were calculated for baseline data only (Table 1, Fig. 2).
With regard to the more specific questions on patient
satisfaction the general practitioners obtained higher mean
scores for all dimensions, whereby the differences in
physicians’ competence and personal continuity were
statistically significant (Table 2). As the patients in shared
care answered each item twice (relating to outpatient clinic
and general practice) they were excluded from this specific
subanalysis. This exclusion entailed that the comparison
between the stable patients and the patients who changed
health-care model during the study was not possible either.
Patients’ evaluation of different health-care dimensions
Each patient rated different aspects of health-care dimen-
sions of her/his treatment setting. As explained above the
patients in shared care and the ones who changed health-
care model were excluded from this analysis. The scores of
the two settings ‘general practice’ and ‘outpatient clinic’
were very good at baseline and at follow-up visits, but the
Table 2 Patients’ view of their own healthcare model1
Month 0 Month 12
General practice
Speciality
outpatient clinic P General practice
Speciality
outpatient clinic P
No. of patients 45 33 45 33
Patient satisfaction withy
y physician’s competence2 4.9 7 0.03 4.3 7 0.8 o0.001 4.8 7 0.4 4.1 7 1.0 o0.01
y course of a visit2 4.6 7 0.7 4.2 7 1.0 n.s. 4.5 7 0.7 4.3 7 1.0 n.s.
y personal continuity2 4.7 7 0.6 3.7 7 1.2 o0.001 4.8 7 0.5 3.3 7 1.2 o0.001
My physician gives me enough information3 4.6 7 0.5 4.2 7 0.7 o0.05 4.5 7 0.6 3.8 7 0.9 o0.001
I express myself clearly about my state of health3 4.3 7 0.8 4.1 7 1.0 n.s. 4.3 7 0.7 4.0 7 0.8 n.s.
My physician communicates comprehensibly3 4.6 7 0.5 4.2 7 0.8 o0.01 4.5 7 0.6 3.8 7 0.8 o0.001
It is easy to start talking with my physician and her/his 4.5 7 0.7 4.1 7 0.9 o0.05 4.4 7 0.8 3.8 7 1.2 o0.05
staff3
My physician perceives me as a whole person3 4.6 7 0.7 4.1 7 0.8 o0.01 4.5 7 0.6 3.8 7 1.0 o0.01
My physician always asks for my opinion3 4.4 7 0.7 3.5 7 0.9 o0.001 4.5 7 0.7 3.5 7 1.0 o0.001
I have a say in important decisions regarding my 4.6 7 0.6 4.3 7 0.7 n.s. 4.6 7 0.7 4.0 7 1.0 o0.01
treatment3
My physician trusts me and my statements on my health3 4.4 7 0.6 4.1 7 0.8 n.s. 4.5 7 0.6 3.7 7 1.0 o0.001
I am honest to my physician3 4.7 7 0.6 4.5 7 0.6 n.s. 4.5 7 0.7 4.3 7 0.7 n.s.
I feel I am in good hands with my physician3 4.7 7 0. 4 4.1 7 0.9 o0.001 4.6 7 0.5 3.8 7 1.1 o0.001
I adhere to my physician’s recommendations3 4.3 7 0.7 4.1 7 0.7 n.s. 4.2 7 0.7 4.1 7 0.7 n.s.
My physician wants the best for me3 4.7 7 0.6 4.1 7 0.6 o0.001 4.5 7 0.5 4.0 7 0.9 o0.001
My physician seems to be content with my condition3 4.2 7 0.7 4 7 0.8 n.s. 4.2 7 0.9 4.1 7 0.9 n.s.
I feel friendly towards my physician3 4.6 7 0.6 4.1 7 0.8 o0.01 4.5 7 0.6 3.7 7 1.1 o0.01
I am not inhibited to speak about intimate matters3 4.4 7 1.1 4.3 7 1.0 n.s. 4.3 7 0.9 4.1 7 0.9 n.s.
My physician is not inhibited to speak about intimate 4.6 7 0.5 4.4 7 1.0 n.s. 4.6 7 0.6 4.1 7 1.0 o0.01
matters3
My physician asks about my psychosocial wellbeing3 3.5 7 1.1 2.7 7 1.1 o0.01 3.6 7 1.0 2.3 7 0.9 o0.001
The practice/clinic is at a convenient place for me3 3.8 7 1.1 3.7 7 1.3 n.s. 3.7 7 1.1 3.7 7 1.3 n.s.
I am confident that anonymity is guaranteed3 4.0 7 1.3 3.6 7 1.6 n.s. 4.6 7 0.9 3.8 7 1.3 o0.01
I do not have any problems to co-ordinate appointments 4.4 7 0.9 4.2 7 1.3 n.s. 4.5 7 0.8 4.3 7 1.0 n.s.
with physician with other appointments3
The surgery/clinic is well equipped3 4.4 7 0.8 4.4 7 0.8 n.s. 4.4 7 0.9 4.5 7 0.8 n.s.
My physician can be contacted outside regular times3 4.4 7 0.8 3.5 7 1.3 o0.01 4.3 7 1.0 3.6 7 1.2 o0.01
The surgery/clinic has an agreeable atmosphere3 4.3 7 0.7 3.2 7 1.2 o0.001 4.2 7 0.9 3.0 7 1.0 o0.001
I do not have to wait long3 4.0 7 1.0 4.2 7 1.1 n.s. 4.0 7 1.0 4.4 7 0.9 n.s.
1Mean (7 SD). 2Scale range 1 ‘not satisfied’ to 5 ‘very satisfied’. 3Scale range 1 ‘not true at all’ to 5 ‘very true’.
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general practitioners received significantly higher mean
scores for many items at all study visits (Table 2).
Physicians’ characteristics
The physicians at the specialized outpatient clinic were
younger compared to their colleagues in general practice,
had less clinical experience since graduation, but had seen
more persons with HIV during the previous 12 months
(Table 3).
All of the general practitioners reported having cared for
at least five (range: 5–70) patients with HIV within the
previous 12 months, six of the 10 general physicians
having cared for more than 20 patients.
Discussion
We aimed at comparing two health-care settings for people
with HIV in an urban area of Switzerland: the specialized
university HIV outpatient clinic and general practices.
However, we observed five patient groups during the study
period, patients who: saw a general practitioner exclu-
sively; attended the specialized clinic only; were in shared
care (although enrolled either at the outpatient clinic or at
a general practice); changed healthcare model; or were lost
to follow-up.
At enrolment, the groups of participants were similar
with respect to demographic, psychosocial and clinical
data. With regard to the evaluated indicators for quality of
care we found similarly good results in the different patient
groups: average quality of life and self reported adherence
was high. Also, patients’ overall satisfaction with care was
very good but higher among those attending general
practices or being in shared care. During follow-up, the
differences diminished. Antiretroviral therapy was mostly
provided according to the state-of-the-art. Treatment
outcome as assessed by comparing the proportion of
patients with HIV-1 RNA concentrations below 400 copies/
mL was similar among patients in stable health-care
models, but indicated a higher rate of treatment failure
among patients who were lost to follow-up and among the
group who changed treatment setting during the study. All
participating physicians were involved in continuing
education; the general practitioners had collected experi-
ence over the past in HIV-medicine and are continuing to
do so.
The strength of this observational study is that its
prospective design with follow-up of different patient
groups over 1 year allowed us to compare the patients’
views on their health-care setting, their quality of life,
satisfaction, and adherence to the institution, as well as to
the therapy, with their treatment outcome. Such aspects of
community-based care cannot be approached with a
randomized trial or a cohort study from specialized HIV
centres. Many experts doubt that outcome results obtained
in randomized trials, enrolling highly motivated and
possibly selected patients who are followed in special care
settings, are comprehensive. Our cohort of patients may be
more representative of the community of people with HIV,
also including patients with a drug use history, than a study
population enrolled in clinical trials.
However, this study design has its limitations because
the patients selected the care setting by themselves, and,
although the demographic and clinical data of patient
Table 3 Physicians’ characteristics
General practitioners Specialists at outpatient clinic P
No. of physicians 10 6 n.a.
No. male (%) 8 (80) 3 (50) n.s.
Mean age (7 SD) 47.1 (7 9.2) 36.8 (74.4) o 0.05
Mean years in practice or at clinic (7 SD) 10.9 (7 8.9) 1.0 (7 1.5) o 0.05
No. general practitioners who have ever worked at a HIV-specialized 1 n.a. n.a.
institution
Mean no. years since 1st treatment of HIV-patient (7 SD) 10.6 (7 4.5) 5.5 (7 3.4) o 0.05
Mean no. years since treating patients with HIV in own practice (7 SD) 8.5 7 4.6 n.a. n.a.
Mean no. of treated persons with HIV in last 12 months (7 SD)1 28.4 (721.5) 177.3 (7 119)
Mean estimated proportion of all patients who are HIV-infected attending 15.75 (7 23.4) n.a. n.a.
institution (7 SD)
Mean years since final university examination (7 SD) 19.7 (78.2) 10 (7 4.4) o 0.05
No. with specialist’s training (%) 7 (70) 5 (83.3) n.s.
No. of physicians spending more than 1/3 of a consultation discussing 8 (80) 2 (33.3) n.s.
psycho-social problems (%)
Mean working time spent with people with HIV per week, hours (7 SD) 12.5 (7 10.9) 53.2 (7 4.2) o0.001
1range for general practitioners: 5–70; range for specialists: 40–250. Only three residents had been at the clinic for longer than 12 months. The others had
only been in this department for between 2 weeks and 6 months. This comparison was not made as it makes no sense.
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groups appeared similar, we cannot rule out that we
compared different patient groups. Furthermore, dedication
and HIV-specific knowledge of the 10 participating
practitioners cannot be generalized to other general
practitioners. The participating physicians invest a lot of
time and effort in continuing education, have collected
enough experience in HIV-medicine to keep a high level of
competence and co-operate with the specialists at the
clinic. The results of virologic and immunologic outcome
need to be interpreted with caution because this was not a
controlled trial. Nevertheless, considering that a substantial
number of patients had a long treatment history,
that almost 30% of them had previously suffered from an
AIDS-defining illness and that the median nadir CD4
lymphocyte count was below 200/mL, virologic and
immunologic treatment outcome was favourable with
HIV-1 RNA below 400 copies/mL in 70% of all patients
at month 12. These results are comparable to those of
randomized trials.
Our study shows that people with HIV can be treated by
highly motivated general practitioners with specialist
knowledge. Patients who select this care setting are more
satisfied with it, although patients’ satisfaction was also
excellent at the large specialized institution with a rotating
system of physicians.
As it is frequently observed that patients rate their
satisfaction with care highly when asked in a global way,
more specific questions on patient satisfaction were asked
[21–25]. These results revealed that the patients seeing
general practitioners were more satisfied with the physi-
cian’s competence and the personal continuity provided.
Possibly the physician’s competence was interpreted in a
broad way including patients’ view on communication
skills besides specialists’ medical knowledge. The study
physicians at the clinic on the other hand were mainly
‘junior’ physicians who work in a highly controlled
environment. Skilled senior staff physicians are available
to review the care on a regular basis, and critical decisions,
such as initiation or change of antiretroviral therapy, are
discussed before any action is taken. This may give the
patients the impression of relative incompetence of their
directly treating physician, although the ‘system’ is highly
specialized.
With regard to the evaluation of different health service
dimensions, the general practices received higher rates
concerning the interaction of providers with patients and
accessibility/convenience factors of the setting. One needs
to keep in mind, though, that while these differences may
reflect different features of the settings they do not say
anything about the importance of these aspects for the
individual patient. It may be that some patients do not
want to talk with their physician about the psychosocial
aspects of their life with HIV and, therefore, choose to see a
specialist at the clinic who concentrates more on the
disease management [26].
A finding not considered when we designed the study
was that there is a group of patients who changed health-
care model. Possible reasons for the changes may be
dissatisfaction with their health-care model, bad health
status or low health-related quality of life. Although it
remains unclear which is the cause and which is the effect
of this phenomenon, it appears crucial to further investi-
gate this group in order to offer a tailored treatment setting
and improve outcome for these patients.
We conclude that in the urban area of Zurich a well-
working system offers high-quality healthcare with regard
to somatic treatment as well as psychosocial care to
persons living with HIV. It allows patients to choose a
health-care model according to their preferences (e.g.
concerning the physicians treating style) and their
individual needs (e.g. psychosocial support) [27–31]. On
condition that the general practitioners have a certain level
of experience, continuously keep up with the recent
developments in HIV medicine and are embedded in a
support system that provides specialists’ knowledge, this
model efficiently and effectively utilizes existing teams of
specialty and primary healthcare professionals relying on
their mutual co-operation. It can serve as a model for
providing healthcare in rural and other areas where local
providers have only limited HIV expertise and patients
want to avoid having to commute long distances for their
medical care [5].
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